Trade Report: The Research Analysts’ Recent Ratings Updates for Neurocrine Biosciences (NBIX)

The Research Analysts’ Recent Ratings Updates for Neurocrine Biosciences (NBIX)

A number of firms have modified their ratings and price targets on shares of Neurocrine Biosciences (NASDAQ: NBIX) recently:

Shares of Neurocrine Biosciences Inc. (NASDAQ:NBIX) traded down 4.28% during mid-day trading on Friday, hitting $42.27. The stock had a trading volume of 742,931 shares. The stock’s 50-day moving average price is $50.32 and its 200-day moving average price is $47.58. The firm’s market cap is $3.67 billion. Neurocrine Biosciences Inc. has a 52-week low of $31.25 and a 52-week high of $58.46.

Related posts

Leave a Comment